Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Single-cell immunology of SARS-CoV-2 infection
Gaining a better understanding of the immune cell subsets and molecular factors associated
with protective or pathological immunity against severe acute respiratory syndrome …
with protective or pathological immunity against severe acute respiratory syndrome …
SARS-CoV-2 infection and the antiviral innate immune response
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak began in
December 2019, causing the illness known as the novel coronavirus disease 2019 (COVID …
December 2019, causing the illness known as the novel coronavirus disease 2019 (COVID …
Investigating virological, immunological, and pathological avenues to identify potential targets for developing covid-19 treatment and prevention strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging
coronavirus causing respiratory disease commonly known as COVID-19. This novel …
coronavirus causing respiratory disease commonly known as COVID-19. This novel …
[PDF][PDF] The immunopathobiology of SARS-CoV-2 infection
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to
coronavirus disease 2019 (COVID-19). Virus-specific immunity controls infection …
coronavirus disease 2019 (COVID-19). Virus-specific immunity controls infection …
[HTML][HTML] Molecular perspectives of SARS-CoV-2: pathology, immune evasion, and therapeutic interventions
The outbreak of coronavirus disease 2019 (COVID-19) has not only affected human health
but also diverted the focus of research and derailed the world economy over the past year …
but also diverted the focus of research and derailed the world economy over the past year …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
J Shen, J Fan, Y Zhao, D Jiang, Z Niu, Z Zhang… - Frontiers in …, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus (SARS-CoV-2), has affected all countries worldwide. Although some …
syndrome coronavirus (SARS-CoV-2), has affected all countries worldwide. Although some …
Innate immune response to SARS-CoV-2 infection: From cells to soluble mediators
D Ricci, MP Etna, F Rizzo, S Sandini, M Severa… - International journal of …, 2021 - mdpi.com
The vulnerability of humankind to SARS-CoV-2 in the absence of a pre-existing immunity,
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
M Policard, S Jain, S Rego, S Dakshanamurthy - Virus Research, 2021 - Elsevier
The spread of SARS-CoV-2 and the increasing mortality rates of COVID-19 create an urgent
need for treatments, which are currently lacking. Although vaccines have been approved by …
need for treatments, which are currently lacking. Although vaccines have been approved by …